OSE Immunotherapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 257,926 | 1.19% |
| Private Companies | 788,700 | 3.63% |
| Individual Insiders | 4,634,098 | 21.3% |
| General Public | 16,072,557 | 73.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.6%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 2,007,163 | €19.9m | 0% | no data | |||
| 1,860,049 | €18.5m | 0% | no data | |||
| 788,700 | €7.8m | 0% | no data | |||
| 424,084 | €4.2m | 0% | no data | |||
| 342,802 | €3.4m | 0% | no data | |||
| 135,000 | €1.3m | 0% | 0.15% | |||
| 110,000 | €1.1m | 0% | 0.39% | |||
| 106,900 | €1.1m | 0% | 3.3% | |||
| 6,766 | €67.1k | 0% | 0.01% | |||
| 1,500 | €14.9k | -25% | 0.6% |